David D. Kim

David Kim’s practice focuses on public and private securities offerings. He represents high-growth companies and investment banks in a variety of equity and debt transactions, including initial public offerings, other equity offerings, and high-yield, investment-grade and convertible debt offerings.

David also advises companies with respect to general corporate and securities matters, including corporate governance issues, Exchange Act reporting obligations and stock exchange requirements.

David’s representative transactions include advising:

• The underwriters in Ventyx Biosciences’ $174.3 million IPO
• The underwriters in PROCEPT BioRobotics Corporation’s $188.5 million IPO
• The underwriters in Cue Health’s $230 million IPO
• The underwriters in Health Catalyst’s $258.7 million follow-on offering
• The underwriters in Erasca’s $345 million IPO
• The underwriters in Applied Molecular Transport’s $120.8 million follow-on offering
• The dealer managers in QUALCOMM Incorporated’s $2.2 billion exchange offers of senior notes*
• The dealer managers in T-Mobile US, Inc.’s $2 billion rights offering*
• The initial purchasers in T-Mobile US, Inc.’s $2 billion cash mandatory exchangeable trust securities*
• The underwriters in T-Mobile US, Inc.’s $16 billion equity offering*
• BRP Group, Inc. in their:
  • $229.6 million IPO*
  • $175.2 million follow-on offering*
  • $258.1 million follow-on offering*

*Pre-Cooley experience

Prior to joining Cooley, David was previously a capital markets associate in the New York office of Davis Polk & Wardwell LLP. 

While attending Georgetown University Law Center, David represented social enterprises, nonprofit organizations and select small businesses as a student attorney in the Social Enterprise and Nonprofit Law Clinic. David also interned at the Division of Investment Management of the Securities and Exchange Commission and Kroll Bond Rating Agency, Inc.